Systems biologist Steven Wiley says advancements in two areas—single-cell biology and CRISPR—are poised to transform research.  

The modification of three babies’ genes by He Jiankui drew widespread criticism from scientists.

From artificial intelligence to pluripotent stem cells, this year saw the publication of a bevy of intriguing new methods, as well as tweaks to existing protocols.

For the past 10 years, life science has moved us closer to a complete understanding of what makes us human—our similarities, our differences, and our shared history.

The Scientist’s reporters tracked the development of CAR T cell therapies, explored the Neanderthal DNA in our genomes, and dove into a CRISPR controversy.

From a mass photometer to improved breath biopsy probes, these new products are poised for scientific success.

DNA-responsive polymer gels used for releasing drugs, encapsulating cells, and much more now have greater adaptability thanks to the Cas12a nuclease.

A novel system for customizable DNA-hydrogel manipulations

Two clinical trial participants—one with β-thalassemia and one with sickle cell disease—appeared to benefit from the gene-editing treatments with minimal side effects, according to the companies.